在衰老,阿尔茨海默病和synucleinopathies中tau,粉样蛋白和synuclein病理的模式

在衰老,阿尔茨海默病和synucleinopathies中tau,粉样蛋白和synuclein病理的模式

相关实验视频

Updated: Jun 7, 2025

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

10.5K

Sean J Colloby¹, Kirsty E McAleese¹, Lauren Walker¹

¹Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne NE4 5PL, UK.

Brain : a journal of neurology

|November 12, 2024

概括

不正常的蛋白质模式,包括高酸化 (HP-tau) 和α-synuclein,在阿尔茨海默氏症和勒维体痴呆症之间有所不同. 这些模式与认知能力下降以及视觉幻觉和运动障碍等特定症状相关.

科学领域:

神经科学是一个神经科学.
神经病理学神经病理学
老年学是一门学科.

背景情况:

阿尔茨海默病 (AD) 是通过高酸化 (HP-tau) 和粉样β (Aβ) 病理学来定义的.
勒维体 (LB) 痴呆症,包括勒维体 (DLB) 痴呆症和帕金森病痴呆症 (PDD),以α-synuclein聚合物为特征.
混合的HP-tau,Aβ和α-synuclein病理可以同时发生,使诊断复杂化.

研究的目的:

在人体死后大脑中绘制HP-tau,Aβ和α-synuclein的区域定量病理图.
研究这些蛋白质在健康衰老,AD和LB痴呆症中的空间分布和模式.
为了将病理模式与死前临床特征相关联,包括认知功能和特定症状.

主要方法:

对159个人类死后大脑 (对照组,AD,DLB,混合AD/DLB,PDD) 的分析.
使用组织微阵列,对皮层和皮下区域的HP-tau,Aβ和α-synuclein负荷进行定量评估.
主要组件分析以确定病理模式,随后与临床数据进行相关性和调解分析.

主要成果:

对于HP-tau (皮层,时间-边缘),Aβ (皮层-亚皮层) 和alpha-synuclein (多个模式包括后部时-部和前部时-前部) 确定了不同的区域模式.
认知指标与HP-tau和Aβ模式相关,但在痴呆病例中没有α-synuclein模式.
特定的α-synuclein模式与视觉幻觉和LB痴呆症的运动障碍有关.

结论:

阿尔法-同核素病理在LB痴呆症中表现出明显的模式,可能解释疾病异质性和不同传播.
Aβ和HP-tau病理之间的相互作用影响痴呆症的全球认知.
特定的α-synuclein地形与LB痴呆症的关键临床特征有关,这表明了例行病理评估的潜力.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这就是HP-tau.帕金森氏病痴呆症痴呆症粉样化物-β-β 的存在.患有利维体痴呆症的痴呆症 α-synuclein 是一种同核蛋白.

更多相关视频

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

17.2K

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

09:44

Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

Published on: June 2, 2019

21.3K

相关概念视频

03:03

Amyloid Fibrils

9.3K

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

9.3K

01:26

Alzheimer's Disease: Overview

448

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

448

01:37

Neural Regulation

39.1K

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

39.1K

01:15

Parkinson's Disease: Overview

482

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...